-
In Memoriam 2025: Remembering Voices in Politics, Culture, and Media Estimated reading time: 4 minutes Icons from politics, culture, and media who died in 2025 continue to shape how we think, vote, create, and connect. In memoriam segments like NBC News’ “Meet the Press NOW” tribute help us process collective loss and preserve public memory.…
-
A Look Back at 2025 in Indiana Politics: Power Shifts, Policy Fights, and What’s Next Estimated reading time: 4 minutes Key Takeaways Indiana’s new governor reshaped key state agencies, signaling a more aggressive executive agenda for 2026 and beyond. Data centers emerged as a surprise flashpoint, raising questions about tax breaks, infrastructure strain, and community…
-
New Jeffrey Epstein DOJ Files: What the Latest Trump and Royal Mentions Really Mean Estimated reading time: 5 minutes Key takeaways More than 30,000 new Justice Department documents reveal how widely investigators probed Jeffrey Epstein’s network, including at least 10 potential co-conspirators. Newly surfaced flight records show Donald Trump flew on Epstein’s plane at least…
-
Judge Boasberg’s Ruling on CECOT Deportations: What It Means for Trump’s Immigration Agenda Estimated reading time: 5 minutes Federal Judge James Boasberg ruled that the Trump administration violated due process protections for Venezuelan migrants sent to El Salvador’s CECOT prison. The court said deportations under the 1798 Alien Enemies Act were carried out in defiance…
-
Identity, Doppelgängers, and the Limits of Visual Politics Estimated reading time: 4 minutes People routinely confuse Wall Street Journal columnist Jason L. Riley with fellow journalist Robert George, reflecting how often Black professionals get visually collapsed into a single identity. Riley has dealt with look-alike comparisons since childhood, from being likened to TV actor Gary…
-
Medicare’s New $50 Weight Loss Drug Plan: What Seniors Need to Know Estimated reading time: 5 minutes Key Takeaways Medicare is piloting a new BALANCE model that could give some beneficiaries access to GLP-1 weight loss drugs like Wegovy for about $50 per month. Federal law still bans Medicare from broadly covering weight loss drugs,…






